Clinical Importance of Differentiating Epstein- Barr Virus (EBV)-Positive Plasmacytoma From Plasmablastic Lymphoma: Another Unique Case of EBV-Positive Plasmacytoma in an Immunocompetent Patient

被引:2
作者
Alonso, Adrian M. [1 ]
Saxton, Alyssa S. [1 ]
Lin, Rick Y. [1 ]
Basile, Eric J. [1 ]
Yang, Yu [2 ]
机构
[1] Univ Florida, Internal Med, Coll Med, Gainesville, FL 32611 USA
[2] Univ Florida, Pathol Immunol & Lab Med, Coll Med, Gainesville, FL USA
关键词
immuno-competent; hiv; plasmablastic large b-cell lymphoma; ebv associated lymphoma; solitary bone plasmacytoma;
D O I
10.7759/cureus.40021
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Epstein-Barr virus (EBV)-positive plasmacytoma is a rare and unique plasma cell neoplasm that could arise in immunocompetent individuals. Given the molecular and immunohistochemical similarity of EBV-positive plasmacytomas to their significantly more aggressive counterpart, plasmablastic lymphoma (PBL), providers must distinguish between the two neoplasms. This case elucidates a presentation of EBV-positive plasmacytomas in a healthy, immunocompetent individual originating in the C4/C5 cervical neck region. The patient's clinical presentation, in combination with the surgical pathology from the mass biopsy, pointed toward EBV-positive plasmacytoma. Factors such as cellular proliferation rate, cellular atypia, and immunohistochemical staining help differentiate the two diseases. This case will further help providers in the oncologic world to identify these masses.
引用
收藏
页数:4
相关论文
共 9 条
[1]   Plasmablastic transformation of a pre-existing plasmacytoma: a possible role for reactivation of Epstein Barr virus infection [J].
Ambrosio, Maria R. ;
De Falco, Giulia ;
Gozzetti, Alessandro ;
Rocca, Bruno J. ;
Amato, Teresa ;
Mourmouras, Vasileios ;
Gazaneo, Sara ;
Mundo, Lucia ;
Candi, Veronica ;
Piccaluga, Pier P. ;
Cusi, Maria G. ;
Leoncini, Lorenzo ;
Lazzi, Stefano .
HAEMATOLOGICA, 2014, 99 (11) :E235-E237
[2]   Risk factors for Epstein Barr virus-associated cancers: a systematic review, critical appraisal, and mapping of the epidemiological evidence [J].
Bakkalci, Deniz ;
Jia, Yumeng ;
Winter, Joanne R. ;
Lewis, Joanna E. A. ;
Taylor, Graham S. ;
Stagg, Helen R. .
JOURNAL OF GLOBAL HEALTH, 2020, 10 (01)
[3]   The MYC oncogene is a global regulator of the immune response [J].
Casey, Stephanie C. ;
Baylot, Virginie ;
Felsher, Dean W. .
BLOOD, 2018, 131 (18) :2007-2015
[4]   The biology and treatment of plasmablastic lymphoma [J].
Castillo, Jorge J. ;
Bibas, Michele ;
Miranda, Roberto N. .
BLOOD, 2015, 125 (15) :2323-2330
[5]  
Gibbs JD, 2017, CLIN CASE REP, V5, P1482, DOI 10.1002/ccr3.959
[6]  
He L, 2020, INT J CLIN EXP PATHO, V13, P582
[7]   Epstein-Barr virus-positive plasmacytoma in immunocompetent patients [J].
Loghavi, Sanam ;
Khoury, Joseph D. ;
Medeiros, L. Jeffrey .
HISTOPATHOLOGY, 2015, 67 (02) :225-234
[8]   IG/MYC Rearrangements are the Main Cytogenetic Alteration in Plasmablastic Lymphomas [J].
Valera, Alexandra ;
Balague, Olga ;
Colomo, Luis ;
Martinez, Antonio ;
Delabie, Jan ;
Taddesse-Heath, Lekidelu ;
Jaffe, Elaine S. ;
Campo, Elias .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2010, 34 (11) :1686-1694
[9]   Clinicopathologic and Molecular Characterization of Epstein-Barr Virus-positive Plasmacytoma [J].
Zhou, Ting ;
Cheng, Jinjun ;
Karrs, Jeremiah ;
Davies-Hill, Theresa ;
Pack, Svetlana D. ;
Xi, Liqiang ;
Tyagi, Manoj ;
Kim, Jung ;
Jaffe, Elaine S. ;
Raffeld, Mark ;
Pittaluga, Stefania .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2022, 46 (10) :1364-1379